Akebia Corp (AKBA) - Cash Funds per Share

Symbol and logo of brand akebia.com (AKBA)

The synergy between medical professionals and scientists at Akebia Therapeutics (AKBA) ensures resilience within the biotech industry. The integration of Vafseo into dialysis center networks creates a closed distribution channel, while sales growth has stabilized finances, reducing the need for loans. This cash per share chart demonstrates the business's liquidity, with the value of 0.58 showing the most recent figure for this metric.

Akebia Therapeutics, Inc. (AKBA) Cash per Share: for the period 07/04/2022 - 11/22/2026

Analytical breakdowns for Akebia Therapeutics (AKBA)

- market price and analyst price targets:
Summary company analysis:Akebia - AKBA
Flagship merchandise of Akebia Corp

For Akebia Therapeutics (AKBA), maintaining liquid reserves is critical amid geopolitical risks affecting raw material logistics and the conduct of international clinical trials. This cash per share chart calculates the ratio of total cash holdings to the number of shares outstanding, allowing investors to assess the real value of the cash cushion and the degree of capital protection against operational shocks.